Preprint Review Version 2 Preserved in Portico This version is not peer-reviewed

Development of In Vitro Corneal Models: Opportunity for Pharmacological Testing

Version 1 : Received: 29 September 2020 / Approved: 30 September 2020 / Online: 30 September 2020 (15:04:49 CEST)
Version 2 : Received: 24 October 2020 / Approved: 26 October 2020 / Online: 26 October 2020 (11:45:00 CET)

A peer-reviewed article of this Preprint also exists.

Citi, V.; Piragine, E.; Brogi, S.; Ottino, S.; Calderone, V. Development of In Vitro Corneal Models: Opportunity for Pharmacological Testing. Methods and Protocols, 2020, 3, 74. https://doi.org/10.3390/mps3040074. Citi, V.; Piragine, E.; Brogi, S.; Ottino, S.; Calderone, V. Development of In Vitro Corneal Models: Opportunity for Pharmacological Testing. Methods and Protocols, 2020, 3, 74. https://doi.org/10.3390/mps3040074.

Abstract

Human eye is a specialized organ with complex anatomy and physiology, because it is characterized by different cell types with specific physiological functions. Given the complexity of the eye, ocular tissues are finely organized and orchestrated. In the last few years many in vitro models have been developed, in order to meet the 3Rs principle (Replacement, Reduction and Refinement) for eye toxicity testing. This procedure is highly necessary to ensure that the risks associated with ophthalmic products meet appropriate safety criteria. In vitro preclinical testing is now a well-established practice of significant importance for evaluating the efficacy and safety of cosmetic, pharmaceutical, and nutraceutical products. Along with in vitro testing, also computational procedures, herein described, for evaluating the pharmacological profile of potential ocular drug candidates including their toxicity, are in rapid expansion. In this review the ocular cell types and functionality are described providing an overview about the scientific challenge for the development of three-dimensional in vitro models.

Keywords

3D in vitro models; eye research; in silico analysis; eye anatomy

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (1)

Comment 1
Received: 26 October 2020
Commenter: Simone Brogi
Commenter's Conflict of Interests: Author
Comment: We performed revision of our submitted articles and consequently we uploaded the revised version for a final preprint
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 1


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.